Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
43,490,955
-
Share change
-
-2,336,502
-
Total reported value
-
$403,158,980
-
Put/Call ratio
-
6.9%
-
Price per share
-
$9.27
-
Number of holders
-
115
-
Value change
-
-$23,495,625
-
Number of buys
-
53
-
Number of sells
-
73
Institutional Holders of DECIPHERA PHARMACEUTICALS IN - COM (DCPH) as of Q1 2022
As of 31 Mar 2022,
DECIPHERA PHARMACEUTICALS IN - COM (DCPH) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,490,955 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, STATE STREET CORP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BlackRock Inc., VANGUARD GROUP INC, FEDERATED HERMES, INC., New Leaf Venture Partners, L.L.C., CANADA PENSION PLAN INVESTMENT BOARD, Jefferies Group LLC, and Assenagon Asset Management S.A..
This page lists
115
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.